fda glp 1 compounding During GLP‑1 shortages, expanded to help meet patient needs. With supply stabilizing, guidance has shifted—highlighting why it's important to understand how compounded medications differ from FDA‑approved options. Learn more in FDA to Restrict Ingredients Used
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 277.Fong S., Carollo A., Lazuras L., Corazza O., Esposito G

GLP-1 innovation is moving beyond obesity Drug developers are racing to expand indications to assume market dominance

Global Obesity Drug Market Analysis and Forecasts, By End-users 13.1
Tirzepatides dual GIP/GLP-1 mechanism has demonstrated superior weight-loss efficacy in both clinical trials and real-world studies, enabling stronger payer uptake and prescriber preference
J Hepatol 2023;79:888-97.PubMed 118
These effects make it easier for patients to adhere to lower-calorie diets, further supporting weight loss efforts